Gain Therapeutics GAAP EPS of -$0.17 [Seeking Alpha]
Gain Therapeutics Reports Financial Results for Third Quarter 2024 and Provides Corporate Update [Yahoo! Finance]
Gain Therapeutics Reports Financial Results for Third Quarter 2024 and Provides Corporate Update
Gain Therapeutics Presents Data at 36?? EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics Demonstrating Identification of Allosteric Inhibitors Targeting DDR2
Gain Therapeutics Announces Poster Presentation at 36th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics